132 related articles for article (PubMed ID: 3809585)
1. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma.
Rosen EM; Goldberg ID; Rose C; Come S; Goldstein M; Simon L; Botnick LE
Radiother Oncol; 1986 Nov; 7(3):223-31. PubMed ID: 3809585
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma.
Eifel PJ; Gershenson DM; Delclos L; Wharton JT; Peters LJ
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1013-8. PubMed ID: 1917596
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
5. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
6. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
7. Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinoma.
Haie C; Pejovic-Lenfant MH; George M; Michel G; Gerbaulet A; Prade M; Chassagne D
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):15-9. PubMed ID: 2745190
[TBL] [Abstract][Full Text] [Related]
8. Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma.
Sutton GP; Stehman FB; Einhorn LH; Roth LM; Blessing JA; Ehrlich CE
J Clin Oncol; 1989 Feb; 7(2):223-9. PubMed ID: 2915238
[TBL] [Abstract][Full Text] [Related]
9. [Tolerance and role of irradiation in the treatment of epithelial cancer of the ovary].
Quétin P; Marchal C; Hoffstetter S; Cutuli B; Beckendorf V; Lapeyre M; Peiffert D; Bey P
Cancer Radiother; 1998; 2(4):366-74. PubMed ID: 9755750
[TBL] [Abstract][Full Text] [Related]
10. Combined modality treatment for stage III ovarian carcinoma.
Rizel S; Biran S; Anteby SO; Brufman G; Sulkes A; Milwidsky A; Weshler Z; Fuks Z
Radiother Oncol; 1985 Apr; 3(3):237-44. PubMed ID: 2988025
[TBL] [Abstract][Full Text] [Related]
11. The role of second-look laparotomy in the management of patients with stage II, III and IV ovarian cancers following chemotherapy with cisplatin, adriamycin and cyclophosphamide.
Kirwan PH; Naftalin NJ; Khanna S; Aukett RJ
Br J Obstet Gynaecol; 1986 Jun; 93(6):629-33. PubMed ID: 3730331
[TBL] [Abstract][Full Text] [Related]
12. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
Rothenberg ML; Ozols RF; Glatstein E; Steinberg SM; Reed E; Young RC
J Clin Oncol; 1992 May; 10(5):727-34. PubMed ID: 1569445
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of whole abdominal irradiation in ovarian carcinoma with a four orthogonal fields technique.
Thomas L; Pigneux J; Chauvergne J; Stöckle E; Bussières E; Chemin A; Toulouse C
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1083-90. PubMed ID: 7961015
[TBL] [Abstract][Full Text] [Related]
14. Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity.
Kong JS; Peters LJ; Wharton JT; Ang KK; Delclos L; Gershenson DM; Copeland LJ; Edwards CL; Freedman RS; Saul PB
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):737-43. PubMed ID: 3350729
[TBL] [Abstract][Full Text] [Related]
15. Multimodal approach (surgery, chemotherapy, and radiotherapy) in the treatment of advanced ovarian carcinoma.
Steiner M; Rubinov R; Borovik R; Cohen Y; Robinson E
Cancer; 1985 Jun; 55(12):2748-52. PubMed ID: 4039626
[TBL] [Abstract][Full Text] [Related]
16. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
17. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma.
Fuks Z; Rizel S; Biran S
J Clin Oncol; 1988 Mar; 6(3):509-16. PubMed ID: 3127551
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
20. Whole abdominal irradiation following chemotherapy in advanced ovarian carcinoma.
Kuten A; Stein M; Steiner M; Rubinov R; Epelbaum R; Cohen Y
Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):273-9. PubMed ID: 3338949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
